Ant Group launched DeepSearch, an evidence-based clinical decision support tool integrated into its AQ AI health assistant, offering access to over 36 million medical publications for clinicians.
This move signals Ant Group's deepening commitment to the healthcare sector, leveraging its AI capabilities to address practical challenges for medical professionals in China. It also highlights the growing trend of major tech companies developing specialized AI tools for vertical industries, potentially reshaping the landscape of digital health in the APAC region.
Ant Group launched DeepSearch, a free evidence-based clinical decision support tool for its AI health assistant AQ.
The tool provides access to over 36 million Chinese and international medical publications.
AQ's PC platform now offers both Health Q&A and DeepSearch capabilities for medical professionals.
Ant Group's DeepSearch launch in China sets a precedent for AI-driven clinical support in APAC. Its success could spur similar innovations from regional tech giants like Tencent or Grab, intensifying competition in digital health. Regulatory frameworks for medical AI and data privacy across markets like India, Indonesia, and Singapore will be crucial for future expansion, influencing market entry strategies.
AQ's PC platform now offers both Health Q&A and DeepSearch capabilities for medical professionals.
The AQ app has reached 30 million monthly active users in China.
Sign in to save notes on signals.
Sign In